UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 7
July-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2407616


Registration ID:
543542

Page Number

g129-g141

Share This Article


Jetir RMS

Title

Povidone iodine (Betadine) spray for upper respiratory tract infections: Two pilots randomized controlled studies

Abstract

Povidone-iodine (PVPI) sprays may benefit patients with upper respiratory tract inflammations (URTI). This study evaluated the efficacy of PVPI nasal and throat sprays in patients with URTI and their effect on bacterial and viral loads. Two double-blind pilot studies enrolled 10 patients each with rhinitis and pharyngitis/tonsilitis, respectively. In the nasal spray (NS) study, the test spray was PVPI (0.5% w/v) and in the throat spray (TS) study, it was PVPI (0.45% w/v). In addition to standard therapy, patients randomly received either test (n=5) or placebo (n=5) by self-administration as 2–3 sprays, 3 times daily. Evaluations included changes in the total nasal symptoms score (TNSS) in the NS study, in pharyngitis/tonsilitis symptoms on a 5-point Likert scale in the TS study, and in bacterial and viral loads in both studies. By Day 5, in the NS study, the PVPI group showed a greater reduction in TNSS from baseline (97.30% versus 84.21% in placebo) and the virus was detected in fewer patients (1 versus 3 at baseline). In the TS study, by Day 5, in the PVPI group, the mean Likert score of pharyngitis/tonsilitis symptoms had reduced more (93.75% versus 85.71% in the placebo group) and the virus was detected in fewer patients (none versus 4 at baseline). In both studies, normal bacterial flora growth was not significantly affected and no adverse events were reported. Nasal and throat sprays of PVPI as adjuvant therapy may reduce symptoms and viral loads without major alterations in normal bacterial flora growth. Larger trials are needed to confirm.

Key Words

Povidone iodine; nasal spray; throat spray; rhinitis; pharyngitis; tonsillitis

Cite This Article

"Povidone iodine (Betadine) spray for upper respiratory tract infections: Two pilots randomized controlled studies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 7, page no.g129-g141, July-2024, Available :http://www.jetir.org/papers/JETIR2407616.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Povidone iodine (Betadine) spray for upper respiratory tract infections: Two pilots randomized controlled studies", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 7, page no. ppg129-g141, July-2024, Available at : http://www.jetir.org/papers/JETIR2407616.pdf

Publication Details

Published Paper ID: JETIR2407616
Registration ID: 543542
Published In: Volume 11 | Issue 7 | Year July-2024
DOI (Digital Object Identifier):
Page No: g129-g141
Country: Hyderabad, Telangana, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000607

Print This Page

Current Call For Paper

Jetir RMS